Categories AlphaGraphs, Earnings, Finance

MA Earnings: Mastercard Q1 2022 profit, revenue beat estimates

Mastercard Incorporated (NYSE: MA) reported higher earnings and revenues for the first quarter of 2022. The results also exceeded analysts’ estimates. The credit card giant’s stock traded higher early Thursday soon after the announcement.

Mastercard Q1 2022 earnings infographic

Adjusted earnings, excluding special items, climbed to $2.76 per share in the March quarter from $1.74 per share a year earlier and topped analysts’ estimates. First-quarter unadjusted net income rose to $2.6 billion or $2.68 per share from $1.8 billion or $1.83 per share in the same period of 2021.

At $5.2 billion, net revenues were up 24% year-over-year and well above the consensus forecast. Gross dollar volume increased 17% and purchase volume moved up 21%, on a local currency basis.


Check this space to read management/analysts’ comments on Mastercard’s Q1 2022 results


“We continue to make good progress against our strategic priorities, deepening relationships with key issuers and co-brand partners across the globe. We’re seeing strong traction in consumer and small business payments, Mastercard Installments, and our work across the digital asset space. This complements the continued growth of acceptance and the expansion of our services capabilities through our acquisition of Dynamic Yield,” said Michael Miebach, Mastercard’s CEO.

Prior Performance

_________________________________________________________________________________________________________________

Stocks you may like:

Bank of America (BAC) Stock

Wells Fargo (WFC) Stock

JPMorgan Chase (JPM) Stock

Citigroup (C) Stock

Goldman Sachs (GS) Stock

Morgan Stanley (MS) Stock

_________________________________________________________________________________________________________________

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top